These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112 [TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
5. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma. Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245 [TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy for metastatic colorectal cancer]. Iwasa S; Shimada Y Gan To Kagaku Ryoho; 2008 Sep; 35(9):1467-74. PubMed ID: 18799899 [TBL] [Abstract][Full Text] [Related]
7. Sterically stabilized anti-G(M3), anti-Le(x) immunoliposomes: targeting to B16BL6, HRT-18 cancer cells. Nam SM; Kim HS; Ahn WS; Park YS Oncol Res; 1999; 11(1):9-16. PubMed ID: 10451027 [TBL] [Abstract][Full Text] [Related]
8. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies. Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803 [TBL] [Abstract][Full Text] [Related]
9. Antibodies in the therapy of colon cancer. Welt S; Ritter G Semin Oncol; 1999 Dec; 26(6):683-90. PubMed ID: 10606261 [TBL] [Abstract][Full Text] [Related]
10. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors. Khawli LA; Hu P; Epstein AL Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951 [TBL] [Abstract][Full Text] [Related]
11. Current concepts in immunotherapy for the treatment of colorectal cancer. Indar A; Maxwell-Armstrong CA; Durrant LG; Carmichael J; Scholefield JH J R Coll Surg Edinb; 2002 Apr; 47(2):458-74. PubMed ID: 12018689 [TBL] [Abstract][Full Text] [Related]
16. New strategies to improve the efficacy of colorectal cancer vaccines: from bench to bedside. Mocellin S Curr Opin Investig Drugs; 2006 Dec; 7(12):1052-61. PubMed ID: 17209522 [TBL] [Abstract][Full Text] [Related]
17. 5T4 oncotrophoblast glycoprotein: janus molecule in life and a novel potential target against tumors. Zhao Y; Wang Y Cell Mol Immunol; 2007 Apr; 4(2):99-104. PubMed ID: 17484803 [TBL] [Abstract][Full Text] [Related]
18. Antibody conjugates and therapeutic strategies. McCarron PA; Olwill SA; Marouf WM; Buick RJ; Walker B; Scott CJ Mol Interv; 2005 Dec; 5(6):368-80. PubMed ID: 16394252 [TBL] [Abstract][Full Text] [Related]
19. [Adjuvant and palliative immunotherapy of colorectal carcinoma]. Schlimok G Praxis (Bern 1994); 1997 Sep; 86(39):1517-9. PubMed ID: 9411672 [TBL] [Abstract][Full Text] [Related]
20. Cancer vaccines: an update with special focus on ganglioside antigens. Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]